Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Biarnés

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Ophthalmology|August 26, 2025
Re: Shen et al.: Determinants of four-year visual acuity loss in geographic atrophy: an analysis of Age-Related Eye Disease Study and Age-Related Eye Disease Study 2 (Ophthalmology. 2025;132:785-798)Marc Biarnés
Eye (London, England)|July 3, 2024
Comment on: "Quality of vision clinical outcomes for a new fully-refractive extended depth of focus intraocular lens"Marc Biarnés
Ophthalmology|April 29, 2015
Re: Thompson: Three kinds of lies (Ophthalmology 2014;121:1315-6)Marc Biarnés
Ophthalmology Science|June 22, 2026
Re: "Antropoli A et al. Perilesional fundus autofluorescence patterns are not static: longitudinal transitions in geographic atrophy and association with disease progression"Marc Biarnés
The Lancet. Digital Health|September 12, 2021
Deep learning in geographic atrophy: the best is yet to comeMarc Biarnés
Ophthalmic Research|January 7, 2020
Regression to the Mean in Measurements of Growth Rates in Geographic AtrophyMarc Biarnés, Jordi Monés
Retina (Philadelphia, Pa.)|December 26, 2015
CorrespondenceJordi Monés, Marc Biarnés
The British Journal of Ophthalmology|July 22, 2017
Geographic atrophy phenotype identification by cluster analysisJordi Monés, Marc Biarnés
Translational Vision Science & Technology|January 9, 2019
The Rate of Progression of Geographic Atrophy Decreases With Increasing Baseline Lesion Size Even After the Square Root TransformationJordi Monés, Marc Biarnés
European Journal of Ophthalmology|May 16, 2019
Intravitreal aflibercept efficacy in neovascular age-related macular degeneration with suboptimal response to anti-vascular endothelial growth factor-A therapyJordi Monés, Marc Biarnés,
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Ophthalmology|August 26, 2025
Re: Shen et al.: Determinants of four-year visual acuity loss in geographic atrophy: an analysis of Age-Related Eye Disease Study and Age-Related Eye Disease Study 2 (Ophthalmology. 2025;132:785-798)Marc Biarnés
Eye (London, England)|July 3, 2024
Comment on: "Quality of vision clinical outcomes for a new fully-refractive extended depth of focus intraocular lens"Marc Biarnés
Ophthalmology|April 29, 2015
Re: Thompson: Three kinds of lies (Ophthalmology 2014;121:1315-6)Marc Biarnés
Ophthalmology Science|June 22, 2026
Re: "Antropoli A et al. Perilesional fundus autofluorescence patterns are not static: longitudinal transitions in geographic atrophy and association with disease progression"Marc Biarnés
The Lancet. Digital Health|September 12, 2021
Deep learning in geographic atrophy: the best is yet to comeMarc Biarnés
Ophthalmic Research|January 7, 2020
Regression to the Mean in Measurements of Growth Rates in Geographic AtrophyMarc Biarnés, Jordi Monés
Retina (Philadelphia, Pa.)|December 26, 2015
CorrespondenceJordi Monés, Marc Biarnés
The British Journal of Ophthalmology|July 22, 2017
Geographic atrophy phenotype identification by cluster analysisJordi Monés, Marc Biarnés
Translational Vision Science & Technology|January 9, 2019
The Rate of Progression of Geographic Atrophy Decreases With Increasing Baseline Lesion Size Even After the Square Root TransformationJordi Monés, Marc Biarnés
European Journal of Ophthalmology|May 16, 2019
Intravitreal aflibercept efficacy in neovascular age-related macular degeneration with suboptimal response to anti-vascular endothelial growth factor-A therapyJordi Monés, Marc Biarnés,
Pageof 6